Yoshiro Banno, MPH

Principal at Catalys Pacific, with over 12 years of investment banking experience at JP Morgan and Morgan Stanley, primarily focused on cross-border M&A advisory and capital markets. He also has been involved in healthcare policy research and analysis at the Health and Global Policy Institute. He joined Renalys Pharma after serving as the CFO at Xcoo (tenku:), Inc., a cutting-edge genomics startup originated from the University of Tokyo.

Yoshiro graduated from the University of Tokyo (BA in Law), and holds an MPH from the Harvard T.H. Chan School of Public Health.